Effect of exposure to ulipristal acetate on sperm function

European Journal of Contraception and Reproductive Health Care

Volumn 17, Issue 6, 2012, Pages 428-437

  Munuce, María José ^a   Zumoffen, Carlos ^a   Cicaré, Juliana ^a   Caille, Adriana ^a   Ghersevich, Sergio ^a   Bahamondes, Luis ^b  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Acrosomal reaction; Sperm function; Spermatozoa; Ulipristal acetate

Indexed keywords

PROGESTERONE RECEPTOR; TYROSINE; ULIPRISTAL;

ACROSOME REACTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MALE; OVARY FOLLICLE FLUID; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPERMATOZOON;

ACROSOME REACTION; CELL SURVIVAL; CONTRACEPTIVES, POSTCOITAL, SYNTHETIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLICULAR FLUID; HUMANS; MALE; NORPREGNADIENES; PHOSPHORYLATION; SPERM CAPACITATION; SPERM MOTILITY; SPERMATOZOA;

EID: 84869413351     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2012.725877     Document Type: Article

References (42)

1. Leonhardt SA, Edwards DP. Mechanism of action of progesterone antagonists. Exp Biol Med (Maywood) 2002;227:969-80. (Pubitemid 36008304)
2. Bahamondes L, Bahamondes MV, Fernandes AM, Monteiro I. Emerging female contraceptives. Expert Opin Emerg Drugs 2011;16:373-87.
3. Bouchard P, Chabbert-Buffet N, Fauser BC. Selective progesterone receptor modulators in reproductive medicine: Pharmacology, clinical efficacy and safety. Fertil Steril 2011;96:1175-89.
4. Brache V, Cochon L, Jesam C, et al. Immediate preovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod 2010; 25:2256-63.
5. Blithe DL, Nieman LK, Blye RP, et al. Development of the selective progesterone receptor modulator CDB-2914 for clinical indications. Steroids 2003;68: 1013-7. (Pubitemid 37532426)
6. Stratton P, Levens ED, Hartog B, et al. Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914. Fertil Steril 2010;93:2035-41.
7. Durand M, del Carmen Cravioto M, Raymond EG, et al. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception 2001;64:227-34. (Pubitemid 34020817)
8. Richardson AR, Maltz FN. Ulipristal acetate: Review of the efficacy and safety of a newly approved agent for emergency contraception. Clin Ther 2012; 34:24-36.
9. Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: A randomised non-inferiority trial and meta-analysis. Lancet 2010;375:555-62.
10. Guidobaldi HA, Teves ME, Uñates DR, Giojalas LC. Sperm transport and retention at the fertilization site is orchestrated by a chemical guidance and oviduct movement. Reproduction 2012;143:587-96.
11. Munuce MJ, Caille AM, Botti G, Berta CL. Modulation of human sperm function by follicular fluid. Andrologia 2004;36:395-401. (Pubitemid 39540778)
12. World Health Organization. Laboratory manual for the examination and processing of human semen, 5th edn. Geneva: WHO Press 2010.
13. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
14. Osman RA, Andria ML, Jones AD, Meizel S. Steroid induced exocytosois: the human sperm acrosome reaction. Biochem Biophys Res Commun 1989;160:828-33. (Pubitemid 19140601)
15. Tesarik J, Mendoza C, Moss J, Carreras A. Selective expression of progesterone receptor on the human sperm surface. Fertil Steril 1992;58:784-92.
16. Blackmore P, Beebe S, Danforth D, Alexander N. Progesterone and 17-hydroxyprogesterone. Novel stimulators of calcium influx in human sperm. J Biol Chem 1990;265:1376-80.
17. Blackmore PF, Lanttazio F. Cell surface localization of a novel non-genomic progesterone receptor on the head of human sperm. Biochem Biophys Res Commun 1991; 181:331-6.
18. Baldi E, Luconi M, Muratori M, et al. Nongenomic activation of spermatozoa by steroid hormones: Facts and fictions. Mol Cell Endocrinol 2009;308:39-46.
19. Bouchard P. Current and future medical treatments for menometrorrhagia during the premenopause. Gynecol Endocrinol 2011;27 (Suppl. 1):1120-5.
20. Croxtall JD. Ulipristal acetate: In uterine fibroids. Drugs 2012;72:1075-85.
21. Wang C, Sinha-Hikim A, Leung A. The anti-progestin CDB 2914 has no antifertility effect in male rats. Contraception 1995;51:215-8.
22. Yanagimachi R. Mammalian fertilization. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press 1988:135-85.
23. Urner F, Sakkas D. Protein phosphorylation in mammalian spermatozoa. Reproduction 2003;125:17-26. (Pubitemid 36231207)
24. Emiliozzi, C, Fenichel P. Protein tyrosine phosphorylation is associated with capacitation of human sperm in vitro but is not sufficient for its completion. Biol Reprod 1997;56:674-9. (Pubitemid 27084104)
25. Visconti PE, Bailey JL, Moore GD, et al. Capacitation of mouse spermatozoa. I. Correlation between the capacitation state and protein tyrosine phosphorylation. Development 1995;121:1129-37.
26. Visconti PE, Moore GD, Bailey JL, et al. Capacitation of mouse spermatozoa. II. Protein tyrosine phosphorylation and capacitation are regulated by cAMP-dependent pathway. Development 1995;121:1139-50.
27. Munuce MJ, Marín-Briggiler CI, Caille AM, et al. Modulation of human sperm function by peritoneal fluid. Fertil Steril 2003;80:939-46. (Pubitemid 37230031)
28. Zumoffen CM, Caille AM, Munuce MJ, et al. Proteins from human oviductal tissue-conditioned medium modulate sperm capacitation. Hum Reprod 2010;25:1504-12.
29. Luconi M, Bonaccorsi L, Krausz C, et al. Stimulation of protein tyrosine phosphorylation by platelet-activating factor and progesterone in human spermatozoa. Mol Cell Endocrinol 1995;108:35-42.
30. Tesarik J, Moos J, Mendoza C. Stimulation of protein tyrosine phosphorylation by a progesterone receptor on the cell surface of human sperm. Endocrinology 1993; 133:328-35. (Pubitemid 23206412)
31. Tomes CN, Carballada R, Moses DF, et al. Treatment of human spermatozoa with seminal plasma inhibits protein tyrosine phosphorylation. Mol Hum Reprod 1998; 4:17-25. (Pubitemid 28109156)
32. Calvo L, Vantman D, Banks S, et al. Follicular fluid induced acrosome reaction distinguishes a subgroup of men with unexplained infertility not identified by semen analysis. Fertil Steril 1989;52:1048-54. (Pubitemid 20011258)
33. Jaiswal BS, Cohen-Dayag A, Tur-Kaspa I, Eisenbach M. Sperm capacitation is, after all, a prerequisite for both partial and complete acrosome reaction. FEBS Lett 1998;427:309-13. (Pubitemid 28225081)
34. Jaiswal BS, Eisenbach M, Tur-Kaspa I. Detection of partial and complete acrosome reaction in human spermatozoa: Which inducers and probes to use? Mol Hum Reprod 1999;5:214-9. (Pubitemid 29104933)
35. Köhn FM, Mack SR, Schill WB, Zaneveld LJ. Detection of human sperm acrosome reaction: comparison between methods using double staining, Pisum sativum agglutinin, concanavalin A and transmission electron microscopy. Hum Reprod 1997;12:714-21. (Pubitemid 27223036)
36. Jang S, Lee Yi L SH. RU 486 suppresses progesteroneinduced acrosome reaction in boar spermatozoa. J Biochem Molecular Biol 2002;35:604-8. (Pubitemid 43142918)
37. Hermanny A, de Nascimento J, Fazano F, et al. Effect of levonorgestrel as emergency contraception upon spermatozoa functions: A review. Expert Rev Obstet Gynecol 2012;7:123-30.
38. Yang J, Serres C, Philibert D, et al. Progesterone and RU 486: Opposing effects on human sperm. Proc Natl Acad Sci USA 1994;91:529-33. (Pubitemid 24041435)
39. Yang J, Jouannet P. RU 486 and calcium fluxes in human spermatozoa. Biochem Biophys Res Commun 1994;204:1009-15. (Pubitemid 24367152)
40. Ambhaikar M, Puri C. Cell surface binding sites for progesterone on human spermatozoa. Mol Hum Reprod 1998;4:413-21. (Pubitemid 28253201)
41. Baulieu EE. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science 1989;245:1351-7.
42. Lishko PV, Botchkina IL, Kirichok Y. Progesterone activates the principal Ca2? channel of human sperm. Nature 2011;471:387-91.